Newsbenzinga
Kiora Pharmaceuticals Released Preclinical Data Showing That KIO-300 Significantly Suppressed Seizure-associated Electrophysiological Activity In An Ex Vivo Temporal Lobe Epilepsy Model
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…